Stonehage Fleming Financial Services Holdings LTD Oramed Pharmaceuticals Inc. Transaction History

Stonehage Fleming Financial Services Holdings LTD

  • $3.78 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Oct 11, 2019
SELL
$2.95 - $3.64 $226,881 - $279,948
-76,909 Closed
0 $0
Q4 2018

Oct 11, 2019
BUY
$3.0 - $4.94 $230,727 - $379,930
76,909 New
76,909 $231,000

Others Institutions Holding ORMP

# of Institutions
63
Shares Held
7.4M
Call Options Held
4K
Put Options Held
2.1K
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Stonehage Fleming Financial Services Holdings LTD Portfolio

Follow Stonehage Fleming Financial Services Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email